AzTrials
AzTrials

Bone Facial BoneNCT06455176

Delayed Secondary Reconstruction of Alveolar Clefts Using Autogenous Symphyseal Particulate Bone Versus Iliac Cancellous Bone: A Randomized Clinical Trial

A study testing alveolar cleft Grafting from the symphysis and alveolar cleft Grafting from the iliac cancellous bone in people with Bone Facial Bone, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients with alveolar clefts whose ages are after 12 years (after eruption of all permanent dentition) were recruited and treated either by particulate bone grafting from the symphysis or from the anterior iliac crest Read more about this study

Who is it for?
Ages 12 to 25 years
Conditions the study is for
Bone Facial Bone
What is being tested?
alveolar cleft Grafting from the symphysis and alveolar cleft Grafting from the iliac cancellous bone
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
Oct 2024to Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 25 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • cleft alveolus patients of both genders after eruption of all permanent dentition

Who cannot join

  • previous failed repairs of alveolar clefts and bone metabolic diseases

About this study

Patients with alveolar clefts whose ages are after 12 years (after eruption of all permanent dentition) were recruited and treated either by particulate bone grafting from the symphysis or from the anterior iliac crest

Being tested
alveolar cleft Grafting from the symphysis, alveolar cleft Grafting from the iliac cancellous bone

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • alveolar cleft Grafting from the symphysisProcedure or surgery

    grafting using particulate bone from the symphysis

  • alveolar cleft Grafting from the iliac cancellous boneProcedure or surgery

    grafting using iliac cancellous bone

Study groups in NCT06455176
Study groupRoleWhat they receive
Symphyseal bone groupActive comparatorNot described
Receives: Procedure: alveolar cleft Grafting from the symphysis
iliac cancellous bone groupActive comparatorNot described
Receives: Procedure: alveolar cleft Grafting from the iliac cancellous bone

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. bone volume in the reconstructed cleft site

    Measured: six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2024
  2. Study startOct 2024 (estimated)
  3. Primary completionDec 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06455176
Sponsor's protocol ID
Cairo uni research
Status last verified
Jun 2024
First submitted
7 Jun 2024
Last updated
12 Jun 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing alveolar cleft Grafting from the symphysis and alveolar cleft Grafting from the iliac cancellous bone in people with Bone Facial Bone, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 12 Jun 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

bone volume in the reconstructed cleft site (time frame: six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in